Study Confirms That Steroids Save Very Ill COVID Patients
September 3, 2020
By Neozene

The following article originally appeared in FiercePharma and was written by Angus Liu When researchers in the U.K. said in June that the low-cost corticosteroid dexamethasone could reduce death rates in critically ill COVID-19 patients, clinicians still had doubts about whether to change their treatment practice without full data. But findings from a series of clinical trials from around the world, along with a new meta-analysis—all of which were published on Wednesday in JAMA—will likely change that. The findings “provide definitive data that corticosteroids should be first-line treatment for critically ill patients

Read More

Congress Urges FDA to Better Scrutinize COVID-19 Antibody Tests
April 27, 2020
By Neozene

This article originally appeared in FierceBiotech and was written by Conor Hale Members of Congress have called on the FDA to re-evaluate its stance toward COVID-19 antibody tests. Since mid-March, the agency has allowed diagnostic developers to bring their products to market without any outside evaluation that the results they produce are accurate. Instead, these manufacturers can proceed after validating the tests themselves, but they are not required to share those results. Companies must also print labels saying their antibody tests are not FDA approved or authorized and should not be used

Read More

‘Nano-Immunotherapy’ Halts Glioblastoma in Mice
August 29, 2019
By Neozene

This article originally appeared in FierceBiotech and was written by Arlene Weintraub One of the most difficult challenges in treating the brain cancer glioblastoma is that few drugs can pass through the blood-brain barrier. Scientists at Cedars-Sinai in Los Angeles have developed a system to circumvent this hurdle—one that combines a powerful immuno-oncology drug with a polymer-based delivery vehicle that can cross the blood-brain barrier. The researchers showed that this “nano-immunotherapy” treatment crossed the blood-brain barrier in mouse models of glioblastoma, and that it stopped tumor cells from multiplying. They

Read More